Vaccine News and Research

Latest Vaccine News and Research

Three leading experts urge US government to be vigilant against anti-vaccination advocates

As the world watches how UK residents respond to COVID-19 vaccinations, three leading experts on the virus are urging Americans and the US government to be vigilant against anti-vaccination advocates and their "rumors, misinformation, and conspiracy theories in a fractured media universe."

11 Dec 2020

IGC researchers receive three out of six European Research Council grants

Since the establishment of the European Research Council in 2008, the IGC has secured 17 of their competitive grants (7 Starting, 8 Consolidator and 2 Advanced).

10 Dec 2020

Researchers find new method for safe and effective delivery of medicines to the lungs

Investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School recently identified a new method for safe and effective delivery of medicines to the lungs that can be used for multiple clinical applications, potentially including aerosol vaccination.

10 Dec 2020

New polio vaccine is the first to work on mutated form of the virus

A new polio vaccine that could tackle mutated strains of the disease has passed phase II clinical trials, according to two studies published in medical journal The Lancet.

10 Dec 2020

$20.6 billion to restore crumbling services for women, newborns, children and adolescents

The COVID-19 pandemic is threatening three decades of improvement in health and social services for women, newborns, children and adolescents.

10 Dec 2020

KHN’s ‘What the Health?’: Vaccines coming soon but COVID relief bill still stalled

The first vaccine to protect against COVID-19 could be approved in the U.S. within days, but legislation to help fund its distribution remains mired in Congress.

10 Dec 2020

Researchers develop new serological assay for detection of SARS-CoV-2 antibodies

Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19.

10 Dec 2020

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

As part of its Wave 1 Pipeline Market Opportunity Call, Takeda Pharmaceutical Company Limited provided an update on its pipeline portfolio, which has the potential to contribute significantly to revenue growth for the company over the next decade.

From Takeda 10 Dec 2020

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.

From EKF Diagnostics 10 Dec 2020

National lung health organizations urge universal vaccine adoption to end COVID-19 pandemic

As COVID-19 cases surge in the U.S., the nation is waiting for the availability of a safe and effective vaccine.

10 Dec 2020

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

South African study data were used to evaluate the safety of the vaccine in the results just published, but not its efficacy [which refers to the percentage reduction of disease].

9 Dec 2020

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

Flaviviruses -- a group of viruses transmitted by ticks or mosquitoes -- infect an estimated 400 million people annually with diseases like yellow fever, Dengue fever, West Nile virus, and, most recently, Zika virus.

9 Dec 2020

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

A recent study by US researchers, currently available on the medRxiv preprint server, evaluated several cell-based assays that are under validation for determining correlates of protection in individuals with symptomatic coronavirus disease (COVID-19) and vaccine studies – and demonstrated their high concordance with both live and pseudotyped virions.

9 Dec 2020

Obesity increases the risk of severe COVID-19, study finds

Researchers reveal that being overweight and obese are common risk factors for developing severe COVID-19. However, they suggested further assessment of metabolic parameters, including body mass index (BMI), waist-hip ratio, and insulin levels, to estimate the risk.

9 Dec 2020

UofL receives DoD funding to develop a nasal spray for preventing COVID-19

The University of Louisville has received funding from the U.S. Department of Defense (DoD) to develop a nasal spray to prevent serious viral respiratory infections such as COVID-19 using Q-Griffithsin, a drug compound developed and co-owned by UofL.

9 Dec 2020

Considerable COVID-19 vaccination hesitancy in UK may affect herd immunity, study finds

Scientists from the Imperial College London and the Imperial College Healthcare NHS Trust, UK, have conducted a cross-sectional, questionnaire-based survey to evaluate the public’s willingness to receive coronavirus disease 2019 (COVID-19) vaccination and their attitude toward prioritization.

9 Dec 2020

It’s time to scare people about COVID

I still remember exactly where I was sitting decades ago, during the short film shown in class: For a few painful minutes, we watched a woman talking mechanically, raspily through a hole in her throat, pausing occasionally to gasp for air.

9 Dec 2020

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease, with no hospitalizations or severe disease reported in the COVID-19 vaccine group so far.

9 Dec 2020

New report underscores the need to implement home care in all pandemic planning

Tens of thousands of Massachusetts residents depend on home care to support their health as they age or cope with physical challenges. That care often requires close personal contact, increasing the risk of contracting COVID-19 among both home-care clients and the aides who provide their care.

8 Dec 2020

Researchers assess the binding behavior of SARS-CoV-2 virus

The binding of a SARS-CoV-2 virus surface protein spike -- a projection from the spherical virus particle -- to the human cell surface protein ACE2 is the first step to infection that may lead to COVID-19 disease.

8 Dec 2020

Vaccine News and Research

Latest Vaccine News and Research

Three leading experts urge US government to be vigilant against anti-vaccination advocates

IGC researchers receive three out of six European Research Council grants

Researchers find new method for safe and effective delivery of medicines to the lungs

New polio vaccine is the first to work on mutated form of the virus

$20.6 billion to restore crumbling services for women, newborns, children and adolescents

KHN’s ‘What the Health?’: Vaccines coming soon but COVID relief bill still stalled

Researchers develop new serological assay for detection of SARS-CoV-2 antibodies

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

National lung health organizations urge universal vaccine adoption to end COVID-19 pandemic

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

Obesity increases the risk of severe COVID-19, study finds

UofL receives DoD funding to develop a nasal spray for preventing COVID-19

Considerable COVID-19 vaccination hesitancy in UK may affect herd immunity, study finds

It’s time to scare people about COVID

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

New report underscores the need to implement home care in all pandemic planning

Researchers assess the binding behavior of SARS-CoV-2 virus

eBook: Advancing infectious disease vaccine development eBook

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Newsletters you may be interested in